Relationships between pharmacokinetic and pharmacodynamic strategies for assessment of the risks for acute rejection and side effects of CellCept.

Trial Profile

Relationships between pharmacokinetic and pharmacodynamic strategies for assessment of the risks for acute rejection and side effects of CellCept.

Completed
Phase of Trial: Phase II

Latest Information Update: 27 May 2016

At a glance

  • Drugs Mycophenolate mofetil (Primary)
  • Indications Renal transplant rejection
  • Focus Pharmacodynamics; Pharmacokinetics; Therapeutic Use
  • Sponsors Roche
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 20 Oct 2008 Status changed from active, no longer recruiting to completed.
    • 09 Jan 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top